Literature DB >> 10962673

Stapedotomy in osteogenesis imperfecta patients.

E Ferekidis1, P Stavroulaki, I Vossinakis, J Yiotakis, L Manolopoulos, G Adamopoulos.   

Abstract

Osteogenesis imperfecta (OI) is a connective tissue disorder characterized by osseous fragility, blue sclerae and hearing loss. In order to assess the impact of stapedotomy on improving hearing on OI, a retrospective, one-group, pre-test-post-test design was used to compare the pre-operative and post-operative audiograms of nine OI patients, treated with stapedotomy for their mixed hearing loss. Operative findings included fixation or thickening of the stapes footplate with normal superstructure configuration and hypervascularization of the promontory mucosa. Immediate post-operative results showed a significant improvement (p < 0.05) from 250-4000 Hz in air conduction and from 250-2000 Hz in bone conduction. A significant closure of the air-bone gap between 250-2000 Hz was also achieved (p < 0.05). The long-term results remained satisfactory with a mean threshold shift of 8 dB HL and an almost unchanged air-bone gap. These satisfactory results and the lack of complications make stapedotomy an appealing method for the management of OI-associated hearing loss.

Entities:  

Mesh:

Year:  2000        PMID: 10962673     DOI: 10.1258/0022215001905986

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  3 in total

1.  Stapes surgery in osteogenesis imperfecta: retrospective analysis of 18 operated ears.

Authors:  M Hijazi; S D Mihailescu; J Horion; A Goldenberg; J P Marie
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-01-12       Impact factor: 2.503

2.  Treatments for hearing loss in osteogenesis imperfecta: a systematic review and meta-analysis on their efficacy.

Authors:  Maialen Ugarteburu; Luis Cardoso; Claus-Peter Richter; Alessandra Carriero
Journal:  Sci Rep       Date:  2022-10-12       Impact factor: 4.996

3.  Hearing loss in osteogenesis imperfecta: characteristics and treatment considerations.

Authors:  Joseph P Pillion; David Vernick; Jay Shapiro
Journal:  Genet Res Int       Date:  2011-12-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.